BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 24684810)

  • 1. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
    Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
    Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
    Reynders A; Brouckaert O; Smeets A; Laenen A; Yoshihara E; Persyn F; Floris G; Leunen K; Amant F; Soens J; Van Ongeval C; Moerman P; Vergote I; Christiaens MR; Staelens G; Van Eygen K; Vanneste A; Van Dam P; Colpaert C; Neven P
    Breast; 2014 Aug; 23(4):453-9. PubMed ID: 24768478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
    Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
    Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems.
    Cho J; Han W; Lee JW; Ko E; Kang SY; Jung SY; Kim EK; Moon WK; Cho N; Park IA; Chung JK; Hwang KT; Kim SW; Noh DY
    Ann Surg Oncol; 2008 Aug; 15(8):2278-86. PubMed ID: 18528729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
    Boler DE; Uras C; Ince U; Cabioglu N
    Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
    Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
    Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
    Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.
    Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH
    Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary node staging for microinvasive breast cancer: is it justified?
    Lyons JM; Stempel M; Van Zee KJ; Cody HS
    Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.